Prophylaxis of Reperfusion Complications in Treatment of Acute Myocardial Infarction in Type 2 Diabetes Mellitus Patients

Purpose — to identify the possibility of improving the outcome of multimodality treatment of acute myocardial infarction (AMI) in type 2 diabetes mellitus (DM) patients by use of a succinate-containing drug.
Materials and methods. The results of examination and treatment of 86 men aged 40 to 70 years with clinical diagnosis of AMI and concomitant type 2 DM were analyzed. The patients were split into two groups depending on use of the succinate-containing drug. Patients of the control group (38 men, 58.3±7.1 years old) received the standard treatment that included percutaneous coronary intervention (PCI). In the main group under study (48 men, 57.6±7.6 years old), the standard therapy complex was complemented with administration of a succinate-containing drug (1.5% succinic acid solution), which was administered first 30–60 minutes prior to PCI intravenously at a dose of 10–12 ml/kg; then, daily once a day, for 5 days at a dose of 5–6 ml/kg. Peculiarities of the AMI clinical course, dynamics of myocardial contractility, values of acid-base balance (ABB), glucose and lactate content, lipid peroxidation (LPO) and antioxidant system (AOS), rheological properties of the blood were evaluated.
Results. During AMI type 2 DM patients developed compensated metabolic lactic acidosis and oxidative distress that manifested in considerable activation of LPO and insufficient activity of the enzymatic component of AOS, blood viscosity grew, elasticity of red blood cells fell. Decreased local and global myocardial contractility was noted as well. During PCI in this category of patients, cardiac rhythm disorders developed in 47.4% of cases, 23.7% of which were life threatening, such as multifocal ventricular extra systole and ventricular fibrillation. 
Conclusion. Administration of a succinate-containing drug during performance of PCI provided correction of the lipid peroxidation processes and rheological properties of the blood in the population studied, facilitated improvement of left ventricle’s systolic and diastolic function, reduced the risk of reperfusion complications.

1. Dedov I.I., Shestakova M.V., Galstyan G.R. Majorov A.Yu. Algorithms of specialized medical care for patients with diabetes mellitus. ed. I.I. Dedov, M.V. Shestakov (7-j vypusk). Saharnyj diabet.2015; 18 (1S): 1- 112 [In Russ].

2. Bobrov V.A., Dolzhenko M.N., Dolganich N.V., Kremeneckaya T.A. Reperfusion arrhythmias: the mechanisms of formation. Vrach. Delo 2000; 6: 36-40 [In Russ].

3. Dorovskikh V.A., Simonova N.V., Pereverzev D.I., Yurtaeva E.Yu., Shtarberg M.M. Succinate containing drug for correction of lipid peroxidation processes induced by administration of the carbon tetrachloride. Biull. fiziologii i patologii dykhaniya. Blagoveshhensk. 2017; 63: 75-79. DOI: 10.12737/article_58e45635ed6673.27662564 [In Russ].

4. Bockeria L.A., Alekyan B.G., Buziashvili Yu. I., Golukhova Ye. Z., Nikitina T.G., Staferov A.V., Zakaryan N V ., Kazaryan A.G. Early and late results of coronary artery stenting in patients with coronary heart disease and type 2 diabetes mellitus. Grudnaya i serdechnososudistaya khirurgiya. 2009; 3: 36-43 [In Russ].

5. Abugov S.A., Movsesyants M.Yu. Predictors of microvascular obstruction in patients undergoing primary percutaneous coronary intervention. Spravochnik vracha obshhej praktiki. 2012; 9: 21-26 [In Russ].

6. Okovity S.V., Sukhanov D.S., Zaplutanov V.A., Smagina A.N. Antihypoxants in current clinical practice. Klin. Med. (Mosk.) 2012; 90 (9): 63-68 [In Russ].

7. Ioseliani D.G., Koledinsky A.G., Kuchkina N.V. The Possibility to Limit Reperfusion Injury of Cardiomyocytes Using Intracoronary Cytoprotectors During Endovascular Reperfusion of the InfarctRelated Artery. Mezhdunarodnyj zhurnal intervencionnoj kardioangiologii. 2006; 11: 11-19 [In Russ].

8. Novikov V.E., Levchenkova O.S. Promising directions of search for antihypoxants and targets of their action. . Eksp. Klin. Farmakol. – М., 2013; 76 (5): 37-47 [In Russ].

9. Smirnov A.V., Nesterova O.B., Golubev R.V. Succinic acid and its application in medicine. Part II. Application of succinic acid in medicine. Nefrologiya. 2014; 18 (4): 12-25 [In Russ].

10. Pell V.R., Chouchani E.T., Frezza Ch., Murphy M.P., Krieg Th. Succinate metabolism: a new therapeutic target for myocardial reperfusion injury. Cardiovascular Research. 2016; 111 (2): 134–141. DOI: 10.1093/cvr/cvw100.

11. Simonova N.V., Dorovskih V.A., Simonova N.P. Ultraviolet radiation and oxidative stress. The possibility of phytocorrection. Blagoveshchensk: АGМА, 2014: 140.

12. Pereverzev D.I., Dorovskikh V.A., Simonova N.V., Shtarberg M.A. Effectiveness of cytoflavin in the correction of lipid peroxidation processes in the blood of patients with acute myocardial infarction. Kardiologiya i serdechno-sosudistaya khirurgiya. 2016; 5: 42-45. DOI: 10.17116/kardio20169542-45 [In Russ].

13. Gerasimov L.V., Moroz V.V., Isakova A.A. Microrheological Disorders in Critical Conditions . Obshchaya reanimatologiya = General Reanimatology. 2010;6 (1): 74. [In Russ].

14. Gerasimov L.V., Marchenkov Yu.V., Volkov D.P., Rodionov E.P., Izmajlov V.V. Possibility of correction of metabolic disorders with reamberin in acute period of traumatic injury. Anesteziol. Reanimatol. 2015; 6: 50-54 [In Russ].

15. Nowicka-Usenko L.V., Tsarev A.V. Cardioprotective Effect of Reamberin in Ischemic – Reperfusion Injury. Obshchaya Reanimatologiya=General Reanimatology. 2016;12 (4): 49-56. DOI: 10.15360/1813-9779-2016-4-49-56 [In Russ, In Engl.].

16. Mazina N.K., Sheshunov I.V., Mazin P.V. Adjuvant energy protection with reamberin in practice of intensive care and resuscitation: metaanalysis data about effectiveness (systematic review) . Anesteziol. Reanimatol. 2016; 4: 314-319. [In Russ].

17. Mashkovsky M.D. Medicinal products. Moscow: Novaya Volna; Umerenkov; 2016: 1216. ISBN: 978-5-7864-0303-0. [In Russ].

18. Bilenko M.V. Ischemic and reperfusion disorders in organs: molecular mechanisms, ways of prevention and treatment. ed. M.V.Bilenko .- М.: Medizina, 1989: 367. ISBN 5-225-00747-3 [In Russ].

19. Abakumov M.M., Davydov B.V., Golikov A.P., Golikov P.P., Polumiskov V.Yu., Matveyev S.B. The method of integral assessment of oxidative stress in emergency conditions / Patent for invention No. 2002105650/15; patent holder N.V. Sklifosovsky Moscow City Research Institute of Emergency Care. 2002.03.05; publ. March 27, 2004. – 10 s [In Russ]

20. Dementieva I.I., Rojtman Е.V., Nikitina N.A., Azizova O.A., Gagaeva Е.V., Lopukhin Yu.M. Changes in the rheological properties of blood and osmotic resistance of red blood cells with the activation of freeradical processes. Klin. Lab. Diagn. 2001; 3: 42-43 [In Russ].

21. Makarov V.A., Gorbunova N.A. Hemostasis and blood rheology. М.; 2003: 103. ISBN 5-94699-022-5. [In Russ].

22. Shestakov V.A., Aleksandrova N.P. Aggregation of erythrocytes in patients with thromboembolic disorders of the great vessels. Kardiologiia. 1974; 4: 103-107 [In Russ].

23. Born Y. Quantitative investigations into aggregation of blood platelets// Phisiol. (London). 1962; 162: 67.

24. Panova Ye. I., Kruglova N. Ye.Factors associated with cardiac arrhythmias in patients with type 2 diabetes mellitus and myocardial infarction. Klin. Med. (Mosk.) 2008; 1: 23-26 [In Russ].

25. Mikhin V.P. Сytoprotection in cardiology: achievements and prospects. Part 2. Arkh. Vnutr. Med. 2014; 2 (16): 33-41 [In Russ].